Expression of B7 molecules in the eye during Experimental Autoimmune Anterior Uveitis (EAAU)

References

• Broekhuyse RM, Kuhlmann ED, Winkens HJ, Van Vugt AH. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis: I. Induction by a detergent-insoluble, intrinsic protein fraction of the retinal pigment epithelium. Exp Eye Res. 1991;52:465–574.
   Google Scholar
• Bora NS, Kim MC, Kabeer NH etal. Experimental autoim-mune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci. 1995;36:1056–1066.
   Google Scholar
• Bora NS, Woon MD, Tandhasetti MT, Cirrito TP, Kaplan HJ. Induction of experimental autoimmune anterior uveitis by a self-antigen: Melanin complex without adjuvant. Invest Ophthalmol Vis Sci. 1997;38:2171–2175.
   Google Scholar
• Woon MD, Kaplan HJ, Bora NS. Kinetics of cytokine production in experimental autoimmune anterior uveitis (EAAU). Curr Eye Res. 1998;17:955–961.
   Google Scholar
• Girvin AM, Dal Canto MC, Rhee L et al. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: A comparative study using costimula-tory molecule-deficient mice and monoclonal antibody blockade. J Immunol. 2000;164:136–143.
   PubMed Web of Science ®Google Scholar
• Austin HA, Balow JE. Treatment of lupus nephritis. Semin Nephrol. 2000;20:265–276.
   Google Scholar
• Quattrocchi E, Dallman MJ, Feldmann M. Adenovirus-mediated gene transfer of CTLA-41g fusion protein in the suppression of experimental autoimmune arthritis. Arthri-tis Rheum. 2000;43: 1688–1697.
   Google Scholar
• Luhder F, Chambers C, Allison JP, Benoist C, Mathis D. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc Natl Acad Sci USA. 2000;97: 12204–12209.
   Google Scholar
• Shao H, Woon MD, Nakamura S etal. Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci. 2001;42:2016–2021.
   Google Scholar
• Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Ann Rev Immunol. 1996;14: 233–258.
   Google Scholar
• Chambers CA, Allison JP Co-stimulation in T cell responses. Curr Opin Immunol. 1997;9:396–404.
   PubMed Web of Science ®Google Scholar
• Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 cos-timulation: A review. Grit Rev Immunol. 1998;18: 389–418.
   Google Scholar
• Bajorath J, Peach RJ, Linsley PS. Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Sci. 1994;3: 2148–2150.
   Google Scholar
• Chambers CA, Sullivan TJ, Allison JP Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation- dependent activation of CD4(+) T cells. Immunity. 1997;7:885–895.
   PubMed Web of Science ®Google Scholar
• Salomon B, Bluestone JA. Complexities of cd28/b7: ctla-4 costimulatory pathways in autoimmunity and transplanta-tion. Ann Rev Immunol. 2001;19:225–252.
   PubMed Web of Science ®Google Scholar
• Morton PA, Fu XT, Stewart JA etal. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol. 1996;156:1047–1054.
   Google Scholar
• Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med. 1991;173:721–730.
   PubMed Web of Science ®Google Scholar
• Linsley PS, Greene JL, Tan P etal. Coexpression and func-tional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med. 1992;176:1595–1604.
   Google Scholar
• van Parijs L, Sethria MP, Schweitzer AN, Borriello F, Sharpe AH, Abbas AK. Functional consequences of dys-regulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice. J Immunol. 1997;159:5336–5344.
   Google Scholar
• Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL. Func-tional expression of B7/BB1 on activated T lymphocytes. J Exp Med. 1993;177: 845–850.
   Google Scholar
• Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J Exp Med. 1994; 180:631–640.
   Google Scholar
• Caux C, Vanbervliet B, Massacrier C et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med. 1994180:1841-1847.
   PubMed Web of Science ®Google Scholar
• Yokozeki H, Katayama I, Ohki 0 et al. Functional CD86 (B7-2/B70) on cultured human Langerhans cells. J Invest Dermatol. 1996;106:147–153.
   PubMed Web of Science ®Google Scholar
• Engel P, Gribben JG, Freeman GJ et al. The B7-2 (B70) costimulatory molecule expressed by monocytes and acti-vated B lymphocytes is the CD86 differentiation antigen. Blood. 1994;84:1402–1407.
   Google Scholar
• Fleischer J, Soeth E, Reiling N, Grage-Griebenow E, Flad HD, Ernst M. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood mono-cytes. Immunology. 1996;89: 592–598.
   Google Scholar
• Hakamada-Taguchi R, Kato T, Ushijima H, Murakami M, Uede T, Nariuchi H. Expression and co-stimulatory func-tion of B7-2 on murine CD4+ T cells. Eur J Immunol. 1998;28: 865–873.
   Google Scholar
• Kuchroo VK, Das MP, Brown JA etal. B7-1 and B7-2 cos-timulatory molecules activate differentially the Thl/Th2 developmental pathways: Application to autoimmune disease therapy. Cell. 1995;80: 707–718.
   Google Scholar
• Racke MK, Scott DE, Quigley L et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of exper-imental allergic encephalomyelitis. J Clin Invest. 1995;96: 2195–2203.
   PubMed Web of Science ®Google Scholar
• Miller SD, Vanderlugt CL, Lenschow DJ et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 1995;3:739–745.
   PubMed Web of Science ®Google Scholar
• Lenschow DJ, Herold KC, Rhee L et al. CD28/B7 regula-tion of Thl and Th2 subsets in the development of autoim-mune diabetes. Immunity. 1996;5:285–293.
   PubMed Web of Science ®Google Scholar
• Lenschow DJ, Ho SC, Sattar H et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med. 1995;181:1145–1155.
   PubMed Web of Science ®Google Scholar
• Matulonis U, Dosiou C, Freeman G et al. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity: Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol. 1996;156:1126–1131.
   PubMed Web of Science ®Google Scholar
• Manickasingham SP, Anderton SM, Burkhart C, Wraith DC. Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro. J Immunol. 1998;161:3827–3835.
   Google Scholar
• Steptoe RJ, Holt PG, McMenamin PG. Functional studies of major histocompatibility class II-positive dendritic cells and resident tissue macrophages isolated from the rat iris. Immunology. 1995;85 :630–637.
   Google Scholar
• Yi-qun Z, Joost vNR, Kasran A, De Boer M, Ceuppens JL. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int Immunol. 1996;8: 37–44.
   Google Scholar
• Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell. 1995;81:979–982.
   Google Scholar
• Cross AH, Lyons JA, San M, Keeling RM, Ku G, Racke MK. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis. Eur J Immunol. 1999;29:3140–3147.
   Google Scholar
• Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 mole-cules during priming versus restimulation of Th2 but not Thl cytokine production. J Immunol. 1998;161:2762–2771.
   PubMedGoogle Scholar